These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33906537)

  • 21. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream.
    Sanchez C; Keri J
    Clin Cosmet Investig Dermatol; 2022; 15():1357-1366. PubMed ID: 35874458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acne and hormones].
    Faure M
    Rev Prat; 2002 Apr; 52(8):850-3. PubMed ID: 12053793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acne: effect of hormones on pathogenesis and management.
    Shaw JC
    Am J Clin Dermatol; 2002; 3(8):571-8. PubMed ID: 12358558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of acne.
    Toyoda M; Morohashi M
    Med Electron Microsc; 2001 Mar; 34(1):29-40. PubMed ID: 11479771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acne vulgaris: recent advances in pathogenesis and treatment.
    Caro I
    J Fam Pract; 1977 Nov; 5(5):747-50. PubMed ID: 144774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Lee O; Farquhar C; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.
    Clarke SB; Nelson AM; George RE; Thiboutot DM
    Dermatol Clin; 2007 Apr; 25(2):137-46, v. PubMed ID: 17430751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex hormones and acne: State of the art.
    Hu T; Wei Z; Ju Q; Chen W
    J Dtsch Dermatol Ges; 2021 Apr; 19(4):509-515. PubMed ID: 33576151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acne and sebaceous gland function.
    Zouboulis CC
    Clin Dermatol; 2004; 22(5):360-6. PubMed ID: 15556719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spironolactone in adolescent acne vulgaris.
    Dhurat R; Shukla D; Lim RK; Wambier CG; Goren A
    Dermatol Ther; 2021 Jan; 34(1):e14680. PubMed ID: 33326148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clascoterone (Winlevi) for the Treatment of Acne.
    Harris C
    Am Fam Physician; 2021 Jul; 104(1):93-94. PubMed ID: 34264597
    [No Abstract]   [Full Text] [Related]  

  • 35. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
    Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G
    Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From pathogenesis of acne vulgaris to anti-acne agents.
    Cong TX; Hao D; Wen X; Li XH; He G; Jiang X
    Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the mechanism of
    Mahant S; Sahajpal NS; Nanda S
    Future Microbiol; 2021 Oct; 16():1181-1193. PubMed ID: 34615379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormonal factors in etiology of common acne].
    Bergler-Czop B; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2004 May; 16(95):490-2. PubMed ID: 15518435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.